Analysis of a Novel Mechanism of Neuronal Toxicity Produced by an Apolipoprotein E‐Derived Peptide
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The apolipoprotein E (apoE)‐derived peptide (141‐155)2 has a neurotoxic effect, implying that apoE itself could be a source of toxicity in Alzheimer's disease brain. We characterized the toxicity of this peptide on superior cervical ganglion (SCG) neurons and compared the death with the apoptotic death that occurs after nerve growth factor (NGF) deprivation in these cells. A dose of 10 μM apoE (141‐155)2 resulted in the death of ~50% of the neurons within 24 h. Nuclear condensation and DNA fragmentation preceded the death. However, most inhibitors of NGF deprivation‐induced death, including the caspase inhibitor Boc‐aspartyl(O‐methyl)fluoromethyl ketone and genetic deletion of bax‐1‐, had no effect on the toxicity. Inclusion of depolarizing levels of potassium did block the toxicity. Receptor‐associated peptide (RAP), an antagonist for apoE receptors, did not protect cells in either SCG or hippocampal cultures. In addition, RAP had no effect on internalization of the apoE peptide. These data support the observation that apoE (141‐155)2 is neurotoxic but suggest that the neurotoxicity is distinct from classical apoptosis or necrosis. Furthermore, these results indicate that the toxic effect may occur independently of members of the low‐denśity lipoprotein receptor gene family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920
Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Holtzman, D. M., Pitas, R. E., Kilbridge, J., Nathan, B., Mahley, R. W., Bu, G., & Schwartz, A. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9480 · Cited by 349 · cited 2×
“As evidence of this, apoE3 enhances neurite outgrowth under conditions in which apoE4 either has no effect or even reduces neurite length (Nathan et al., 1994; Bellosta et al., 1995; Holtzman et al., 1995).”
BackgroundSelf-citationBellosta, S., Nathan, B. P., Orth, M., Dong, L.-M., Mahley, R. W., & Pitas, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27063 · Cited by 313 · cited 2×
“As evidence of this, apoE3 enhances neurite outgrowth under conditions in which apoE4 either has no effect or even reduces neurite length (Nathan et al., 1994; Bellosta et al., 1995; Holtzman et al., 1995).”
BackgroundFurther observations on hippocampal neurons in dispersed cell culture
Banker, G. A., & Cowan, W. M. (1979) · Journal of Comparative Neurology · doi:10.1002/cne.901870302 · Cited by 285
Narita, M., Bu, G., Holtzman, D. M., & Schwartz, A. L. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020587.x · Cited by 96
Self-citation
Cited by
Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides
Laskowitz, D. T., Thekdi, A. D., Thekdi, S. D., Han, S. K. D., Myers, J. K., Pizzo, S. V., & Bennett, E. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7541 · Cited by 206
A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity
Guo, L., LaDu, M. J., & Van Eldik, L. J. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:205 · Cited by 175
Tolar, M., Keller, J. N., Chan, S., Mattson, M. P., Marques, M. A., & Crutcher, K. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-07100.1999 · Cited by 148
“…and truncated apoE4 cause death of rat hippocampal neurons The toxicity of apoE peptides has previously been demonstrated for lymphocytes, chick sympathetic and cortical neurons, and rat hippocampal neurons (Crutcher et al., 1994; Clay et al., 1995; Tolar et al., 1997; Moulder et al., 1999).”
InfluentialThe presence of apoE4, not the absence of apoE3, contributes to AD pathology
Teter, B., Raber, J., Nathan, B., & Crutcher, K. A. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4305 · Cited by 37
“However, other groups have not found consistent evidence for a role of LRP in mediating the toxicity of apoE or apoE peptides [54].”
ApoE mimetic peptide decreases Aβ production in vitro and in vivo
Minami, S. S., Cordova, A., Cirrito, J. R., Tesoriero, J. A., Babus, L. W., Davis, G. C., Dakshanamurthy, S., Turner, R. S., Pak, D. T., Rebeck, G. W., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-16 · Cited by 34
Metadata
- Authors
- Moulder, K. L., Narita, M., Chang, L. K., Bu, G., & Johnson, E. M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1999-03
- Volume
- 72
- Issue
- 3
- Pages
- 1069-1080
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2034907654
- Cited by
- 34
- References
- 7
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of a Novel Mechanism of Neuronal Toxicity Produced by an Apolipoprotein E‐Derived Peptide. https://app.cochat.ai/papers/10.1046/j.1471-4159.1999.0721069.x
- The paper
- Moulder, K. L., Narita, M., Chang, L. K., Bu, G., & Johnson, E. M. (1999). Analysis of a Novel Mechanism of Neuronal Toxicity Produced by an Apolipoprotein E‐Derived Peptide. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.1999.0721069.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.